Original Source(s)
Related Content
Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML
New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational treatment approach using the targeted therapy ziftomenib for patients with a difficult-to-treat form of acute myeloid leukemia (AML).
Radiologists may misidentify AI images
CT and MRI images were harder to distinguish than radiographs and ultrasound, while subspecialty expertise was associated with greater accuracy.
August 26, 2026
-
4 min
BioHorizons Adds Prolifica Allogeneic Growth Factor to Biomaterials Portfolio
New option uses biphasic protein release to support bone healing and tissue regeneration.
by News Staff
August 26, 2026
-
2 min
